We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Factors You Need to Know Ahead of ProPetro's Q4 Earnings Release
Read MoreHide Full Article
Key Takeaways
PUMP is set to report Q4 results with a projected 13-cent per share loss on $283.28M in revenues.
PUMP's revenues are expected to fall YOY, led by weaker hydraulic fracturing, wireline and cementing.
Total Q4 costs are expected to fall 10.8% year over year, led by lower G&A and D&A expenses.
ProPetro Holding Corp. (PUMP - Free Report) is set to release fourth-quarter 2025 results on Feb. 18. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a loss of 13 cents per share on revenues of $283.28 million.
Let us delve into the factors that are likely to have influenced the oilfield service provider’s performance in the to-be-reported quarter. But first, it is worth taking a look at PUMP’s performance in the last reported quarter.
Highlights of PUMP’s Q3 Earnings & Surprise History
In the last reported quarter, the Midland, TX-based oil and gas equipment and services company reported an adjusted loss per share of 2 cents, which was narrower than the Zacks Consensus Estimate of a loss of 11 cents, caused by a 44.4% year-over-year decrease in costs and expenses. Revenues of $294 million beat the consensus mark of $258 million. Regarding surprise history, PUMP’s earnings beat the Zacks Consensus Estimate in two of the trailing four quarters, met in one and missed in the other one, delivering an average negative surprise of 50.38%.
The Zacks Consensus Estimate for fourth-quarter 2025 earnings has not witnessed any movement in the past seven days. The estimated figure indicates a 1,200% year-over-year decrease. Moreover, the Zacks Consensus Estimate for revenues indicates an 11.63% decline from the year-ago period.
Factors to Consider Ahead of PUMP’s Q4 Release
PUMP's total revenues are expected to have suffered in the quarter to be reported. The company offers a wide spectrum of specialized, complementary services and equipment for the exploration and production of oil and natural gas. Our model predicts the hydraulic fracturing services to generate revenues of $201.1 million, down from $236.9 million in the year-ago period. Wireline revenues are expected to decline 3.8%, while Cementing revenues are projected to decrease 5.2% year over year during the same time.
On a bearish note, the decrease in PUMP’s costs might have positively improved its to-be-reported bottom line. The company’s fourth-quarter total costs and expenses are anticipated to be $302.4 million, representing a 10.8% decrease from the year-ago quarter. General & administrative expenses (including SBC) are projected to fall 18.4% year over year, while Depreciation & Amortization is expected to decline 19.7% and Cost of Services to decrease 1.1% over the same period. Due to the ongoing inflationary pressures, the upward trend in costs is expected to have persisted in the fourth quarter.
What Does Our Model Predict for PUMP?
The proven Zacks model does not conclusively predict an earnings beat for PUMP this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. However, that is not the case here.
PUMP’s Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, for this company is -5.88%.
You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
PUMP’s Zacks Rank: PUMP currently carries a Zacks Rank #4 (Sell).
Stocks With the Favorable Combination
Here are some firms from the other space that you may want to consider, as these have the right combination of elements to post an earnings beat this reporting cycle.
Western Union (WU - Free Report) is a global leader in cross-border money transfer services, enabling individuals and businesses to send and receive funds securely across more than 200 countries and territories. The company offers a range of financial services, including digital payments, money transfers and bill payments. Western Union has an Earnings ESP of +1.51% and a Zacks Rank #3 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The firm is scheduled to release earnings on Feb. 20. WU’s earnings beat the Zacks Consensus Estimate in two of the trailing four quarters and missed in the other two, delivering an average surprise of 0.62%.
Allison Transmission Holdings (ALSN - Free Report) has an Earnings ESP of +7.69% and a Zacks Rank #1 at present. The firm is scheduled to release earnings on Feb. 23. ALSN’s earnings missed the Zacks Consensus Estimate in three of the trailing four quarters and beat in one, delivering an average negative surprise of 1.26%.
Allison Transmission Holdings is a U.S.-based designer and manufacturer of fully automatic transmissions and hybrid propulsion systems for medium and heavy-duty commercial and defense vehicles, serving customers in more than 150 countries.
Axsome Therapeutics (AXSM - Free Report) has an Earnings ESP of +25.71% and a Zacks Rank #3 at present. The firm is scheduled to release earnings on Feb. 23. AXSM’s earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed in one, delivering an average surprise of 8.47%.
Axsome Therapeutics is a U.S. biopharmaceutical company focused on developing and commercializing novel therapies for central nervous system (“CNS”) disorders, including depression, migraine and narcolepsy, with products like Auvelity and Sunosi on the market and a pipeline of additional CNS treatments.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Factors You Need to Know Ahead of ProPetro's Q4 Earnings Release
Key Takeaways
ProPetro Holding Corp. (PUMP - Free Report) is set to release fourth-quarter 2025 results on Feb. 18. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a loss of 13 cents per share on revenues of $283.28 million.
Let us delve into the factors that are likely to have influenced the oilfield service provider’s performance in the to-be-reported quarter. But first, it is worth taking a look at PUMP’s performance in the last reported quarter.
Highlights of PUMP’s Q3 Earnings & Surprise History
In the last reported quarter, the Midland, TX-based oil and gas equipment and services company reported an adjusted loss per share of 2 cents, which was narrower than the Zacks Consensus Estimate of a loss of 11 cents, caused by a 44.4% year-over-year decrease in costs and expenses. Revenues of $294 million beat the consensus mark of $258 million. Regarding surprise history, PUMP’s earnings beat the Zacks Consensus Estimate in two of the trailing four quarters, met in one and missed in the other one, delivering an average negative surprise of 50.38%.
This is depicted in the graph below:
ProPetro Holding Corp. Price and EPS Surprise
ProPetro Holding Corp. price-eps-surprise | ProPetro Holding Corp. Quote
Trend in PUMP’s Estimate Revision
The Zacks Consensus Estimate for fourth-quarter 2025 earnings has not witnessed any movement in the past seven days. The estimated figure indicates a 1,200% year-over-year decrease. Moreover, the Zacks Consensus Estimate for revenues indicates an 11.63% decline from the year-ago period.
Factors to Consider Ahead of PUMP’s Q4 Release
PUMP's total revenues are expected to have suffered in the quarter to be reported. The company offers a wide spectrum of specialized, complementary services and equipment for the exploration and production of oil and natural gas. Our model predicts the hydraulic fracturing services to generate revenues of $201.1 million, down from $236.9 million in the year-ago period. Wireline revenues are expected to decline 3.8%, while Cementing revenues are projected to decrease 5.2% year over year during the same time.
On a bearish note, the decrease in PUMP’s costs might have positively improved its to-be-reported bottom line. The company’s fourth-quarter total costs and expenses are anticipated to be $302.4 million, representing a 10.8% decrease from the year-ago quarter. General & administrative expenses (including SBC) are projected to fall 18.4% year over year, while Depreciation & Amortization is expected to decline 19.7% and Cost of Services to decrease 1.1% over the same period. Due to the ongoing inflationary pressures, the upward trend in costs is expected to have persisted in the fourth quarter.
What Does Our Model Predict for PUMP?
The proven Zacks model does not conclusively predict an earnings beat for PUMP this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. However, that is not the case here.
PUMP’s Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, for this company is -5.88%.
You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
PUMP’s Zacks Rank: PUMP currently carries a Zacks Rank #4 (Sell).
Stocks With the Favorable Combination
Here are some firms from the other space that you may want to consider, as these have the right combination of elements to post an earnings beat this reporting cycle.
Western Union (WU - Free Report) is a global leader in cross-border money transfer services, enabling individuals and businesses to send and receive funds securely across more than 200 countries and territories. The company offers a range of financial services, including digital payments, money transfers and bill payments. Western Union has an Earnings ESP of +1.51% and a Zacks Rank #3 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The firm is scheduled to release earnings on Feb. 20. WU’s earnings beat the Zacks Consensus Estimate in two of the trailing four quarters and missed in the other two, delivering an average surprise of 0.62%.
Allison Transmission Holdings (ALSN - Free Report) has an Earnings ESP of +7.69% and a Zacks Rank #1 at present. The firm is scheduled to release earnings on Feb. 23. ALSN’s earnings missed the Zacks Consensus Estimate in three of the trailing four quarters and beat in one, delivering an average negative surprise of 1.26%.
Allison Transmission Holdings is a U.S.-based designer and manufacturer of fully automatic transmissions and hybrid propulsion systems for medium and heavy-duty commercial and defense vehicles, serving customers in more than 150 countries.
Axsome Therapeutics (AXSM - Free Report) has an Earnings ESP of +25.71% and a Zacks Rank #3 at present. The firm is scheduled to release earnings on Feb. 23. AXSM’s earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed in one, delivering an average surprise of 8.47%.
Axsome Therapeutics is a U.S. biopharmaceutical company focused on developing and commercializing novel therapies for central nervous system (“CNS”) disorders, including depression, migraine and narcolepsy, with products like Auvelity and Sunosi on the market and a pipeline of additional CNS treatments.